Dr. Reddys Labs (RDY) Reports Q4 EPS of $0.47

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/30/2026

1. NOW
2. MSFT
3. GOOGL
4. FTNT
5. EBAY
6. CMG
7. TENB
8. BIIB
9. KLAC
10. ETSY

Go back to Dr. Reddys Labs (RDY) Reports Q4 EPS of $0.47

BofA/Merrill Lynch Downgrades Dr. Reddy's Laboratories (RDY) to Underperform

May 14, 2014 7:41 AM EDT

BofA/Merrill Lynch downgraded Dr. Reddy's Laboratories (NYSE: RDY) from Neutral to Underperform and cut their price target to $42.50 citing poor execution at the operational level.

Analyst Manoj Garg notes Dr Reddys (DRRD) 4Q PAT at Rs4.8bn (up 4% YoY) was -19% below the... More

Morgan Stanley Downgrades Dr. Reddy's Laboratories (RDY) to Equalweight

May 14, 2014 7:32 AM EDT

Morgan Stanley downgraded Dr. Reddy's Laboratories (NYSE: RDY) from Overweight to Equalweight.

For an analyst ratings summary and ratings history on Dr. Reddy's Laboratories click here. For more ratings news on Dr. Reddy's Laboratories click here.

Shares of Dr. Reddy's Laboratories closed at $43.82 yesterday.

... More